(Q52453664)

2 May 2018

title

Side-effects of ivermectin in treatment of onchocerciasis. (English)

1 reference

2 May 2018

0 references

0 references

A Rothova

1

1 reference

2 May 2018

A van der Lelij

2

1 reference

2 May 2018

J S Stilma

3

1 reference

2 May 2018

W R Wilson

4

1 reference

2 May 2018

R F Barbe

5

1 reference

2 May 2018

language of work or name

English

0 references

publication date

1 June 1989

1 reference

2 May 2018

number of pages

3

1 reference

inferred from page(s)

published in

The Lancet

1 reference

2 May 2018

volume

1

1 reference

2 May 2018

issue

8652

1 reference

2 May 2018

page(s)

1439-1441

1 reference

2 May 2018

Fatalities after treatment of onchocerciasis with diethylcarbamazine

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2990136-0

7 January 2021

Collapse during treatment of onchocerciasis with diethylcarbamazine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2990136-0

7 January 2021

Dangerous reactions to treatment of onchocerciasis with diethylcarbamazine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2990136-0

7 January 2021

Changes in visual function and in the posterior segment of the eye during treatment of onchocerciasis with diethylcarbamazine citrate

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2990136-0

7 January 2021

Ocular changes with oral and transepidermal diethylcarbamazine therapy of onchocerciasis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2990136-0

7 January 2021

Ocular and systemic complications of diethylcarbamazine therapy for onchocerciasis: association with circulating immune complexes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2990136-0

7 January 2021

Double-blind study of ivermectin and diethylcarbamazine in African onchocerciasis patients with ocular involvement.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2990136-0

7 January 2021

Efficacy and tolerance of ivermectin in human onchocerciasis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2990136-0

7 January 2021

Comparison of ivermectin and diethylcarbamazine in the treatment of onchocerciasis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2990136-0

7 January 2021

Treatment of onchocerciasis. The ocular effects of ivermectin and diethylcarbamazine.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2990136-0

7 January 2021

Ocular findings in a double-blind study of ivermectin versus diethylcarbamazine versus placebo in the treatment of onchocerciasis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2990136-0

7 January 2021

Effect of single-dose ivermectin therapy on human Onchocerca volvulus infection with onchocercal ocular involvement.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2990136-0

7 January 2021

Community-based treatment with ivermectin.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2990136-0

7 January 2021

Ivermectin: A Potent New Antiparasitic Agent

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2990136-0

7 January 2021

Ivermectin: an update

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2990136-0

7 January 2021

10.1016/S0140-6736(89)90136-0

Identifiers

DOI

1 reference

2 May 2018

PubMed ID

2567440

1 reference

2 May 2018